Items where Author is "Abdelkader, H"
 | Up a level |
Journal article
ABDELKADER, H., FATHALLA, Z., MOHARRAM, H., ALI, T.F.S. and PIERSCIONEK, B., 2018. Cyclodextrin enhances corneal tolerability and reduces ocular toxicity caused by diclofenac. Oxidative Medicine and Cellular Longevity, 2018: 5260976. ISSN 1942-0900
ABDELKADER, H., LONGMAN, M.R., ALANY, R.G. and PIERSCIONEK, B., 2016. Phytosome-hyaluronic acid systems for ocular delivery of L-carnosine. International Journal of Nanomedicine, 11, pp. 2815-2827. ISSN 1178-2013
ABDELKADER, H., LONGMAN, M., ALANY, R.G. and PIERSCIONEK, B., 2016. On the anticataractogenic effects of L-carnosine: is it best described as an antioxidant, metal-chelating agent or glycation inhibitor? Oxidative Medicine and Cellular Longevity, 2016, p. 3240261. ISSN 1942-0900
ABDELKADER, H., SWINDEN, J., PIERSCIONEK, B.K. and ALANY, R.G., 2015. Analytical and physicochemical characterisation of the senile cataract drug dipeptide β-alanyl-L-histidine (carnosine). Journal of Pharmaceutical and Biomedical Analysis, 114, pp. 241-246. ISSN 0731-7085
ABDELKADER, H., ALANY, R.G. and PIERSCIONEK, B., 2015. Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lens. Journal of Pharmacy and Pharmacology, 67 (4), pp. 537-550. ISSN 0022-3573
RAI, U.D.J.P., YOUNG, S.A., THRIMAWITHANA, T.R., ABDELKADER, H., ALANI, A.W.G., PIERSCIONEK, B. and ALANY, R.G., 2015. The suprachoroidal pathway: a new drug delivery route to the back of the eye. Drug Discovery Today, 20 (4), pp. 491-495. ISSN 1359-6446
ABDELKADER, H., PIERSCIONEK, B., CAREW, M., WU, Z. and ALANY, R.G., 2015. Critical appraisal of alternative irritation models: three decades of testing ophthalmic pharmaceuticals. British Medical Bulletin, 113 (1), pp. 59-71. ISSN 0007-1420
ABDELKADER, H., PIERSCIONEK, B. and ALANY, R.G., 2014. Novel in situ gelling ocular films for the opioid growth factor-receptor antagonist-naltrexone hydrochloride: fabrication, mechanical properties, mucoadhesion, tolerability and stability studies. International Journal of Pharmaceutics, 477 (1-2), pp. 631-642. ISSN 0378-5173
